Literature DB >> 1981157

The effect of neuroleptics on cognitive and psychomotor function.

D J King1.   

Abstract

There has been great variability and inconsistency in the reported effects of neuroleptic drugs on cognitive and psychomotor function in both patients and normal controls. Experimental design rather than any particular cognitive or psychomotor test appears to have determined the sensitivity of detection of neuroleptic drug effects. In general, sedative phenothiazines have been found to depress psychomotor function and sustained attention, but higher cognitive functions are relatively unaffected. In the majority of studies of schizophrenic patients, both cognitive function and attention improve with neuroleptic treatment, in parallel with clinical recovery. Negative symptoms are not increased and usually show slight improvement with neuroleptic treatment. Controls are more sensitive than schizophrenic patients to neuroleptic drug-induced impairments. Tolerance has been seen in patients but has not been demonstrated in normal volunteers. The way in which neuroleptics produce their beneficial effects in patients remains unknown. Three main hypotheses to replace early arousal theories are proposed: normalisation of attention, facilitated indirectly by suppression of 'released' limbic dopamine hyperactivity; normalisation of asymmetrical temporohippocampal function; or direct improvement of attentional processing. Studies of the effects of new antipsychotic drugs with selective actions and the development of more reliable and selective tests of psychomotor and cognitive functions are required.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981157     DOI: 10.1192/bjp.157.6.799

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  14 in total

1.  Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia.

Authors:  Blanka Kores Plesnicar; Bojan Zalar; Martina Tomori; Ivan Krajnc
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

Review 2.  Psychomotor slowing in schizophrenia.

Authors:  Manuel Morrens; Wouter Hulstijn; Bernard Sabbe
Journal:  Schizophr Bull       Date:  2006-11-08       Impact factor: 9.306

3.  Dementia as a complication of schizophrenia.

Authors:  P J de Vries; W G Honer; P M Kemp; P J McKenna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

4.  Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function.

Authors:  Garry D Honey; Edith Pomarol-Clotet; Philip R Corlett; Rebekah A E Honey; Peter J McKenna; Edward T Bullmore; Paul C Fletcher
Journal:  Brain       Date:  2005-09-23       Impact factor: 13.501

Review 5.  Amisulpride: a review of its use in the management of schizophrenia.

Authors:  M P Curran; C M Perry
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers.

Authors:  J M Danion; S Peretti; D Grangé; M Bilik; J L Imbs; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosis.

Authors:  Olalla Robles; Arantzazu Zabala; Igor Bombín; Mara Parellada; Dolores Moreno; Ana Ruiz-Sancho; Celso Arango
Journal:  Schizophr Bull       Date:  2009-08-25       Impact factor: 9.306

8.  Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search.

Authors:  J T Coull; B J Sahakian; H C Middleton; A H Young; S B Park; R H McShane; P J Cowen; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

Review 9.  A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.

Authors:  Martin Sarter; Vicente Martinez; Rouba Kozak
Journal:  Psychopharmacology (Berl)       Date:  2008-07-10       Impact factor: 4.530

10.  Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.

Authors:  Katarzyna Kucharska-Pietura; Aneta Tylec; Andrzej Czernikiewicz; Ann Mortimer
Journal:  Med Sci Monit       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.